Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Valero Energy Corporation (VLO) vs Zoetis Inc (ZTS) Price & Performance

Valero Energy CorporationTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Valero Energy Corporation vs Zoetis Inc — how do they compare? Valero Energy Corporation trades at $433.75 (market cap $127.78B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Valero Energy Corporation is far larger — about 4.2× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Valero Energy Corporation for 56 Days and Zoetis Inc for 70 Days on average.

VLOZTS
Market Cap
$127.78B$30.20B
Volume
2,570,2256,175,327
Sector
EnergyHealth
52-Week High
$443.80$147.53
52-Week Low
$156.39$69.09
Typical Hold Time
56 Days70 Days
Enterprise Value
$131.26B$37.76B
Dividend Yield
1.08%2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Valero Energy Corporation

Valero Energy (VLO) trades at $443.80, up 4.65% with strong bullish momentum near its 52-week high. The stock shows robust technical strength with moving averages in bullish alignment, though RSI indicates overbought conditions. Fundamentally, VLO has beaten earnings estimates for three consecutive quarters with Q3 2026 expectations at $20.41 EPS. Revenue declined to $122.69B in 2025 but is projected to recover to $139.4B in 2026, while maintaining strong profitability metrics including 29.31% ROE.

VLO presents a compelling growth story with refining margins supporting cash flow generation, though current valuation at 18.51 P/E appears fair. Key risks include potential diesel export restrictions and cyclical energy demand. Analyst consensus remains bullish with 54% buy ratings and $408.10 price target, though current price exceeds consensus. The stock's Gulf Coast advantage and strong balance sheet provide fundamental support for continued outperformance.

Zoetis Inc

Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal despite mixed moving averages and oscillators. The company shows strong profitability with a 27.69% net income margin and 64.91% ROE, though recent quarterly earnings have been inconsistent. Analyst consensus is a $87.33 price target with no sell ratings. Recent news highlights near-term headwinds in U.S. companion animal sales but underscores long-term resilience and undervaluation.

ZTS presents a compelling value opportunity with a low P/E of 11.92 and robust margins, but faces risks from competitive pressures and volatile earnings. Upside potential exists if the company executes on international growth and maintains its industry-leading profitability, though investors should monitor Q3 2026 results for confirmation of recovery trends.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

VLO
28% Buy72% Sell
Avg holding period · 56 Days
ZTS

No sentiment data available yet.

Top news

Latest headlines on both assets

About Valero Energy Corporation

Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.

Read more on VLO →

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS →